{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-065710","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.647413+00:00","generated_at":"2026-05-18T05:50:25.986242+00:00","sec_items":["5.02","5.08","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Cadrenal director resigns; 2025 annual meeting set for Sept 24, proposal deadline July 28","bullets":["Director Robert Lisicki resigned from board effective July 15, 2025, with no disagreement with the company.","2025 annual meeting scheduled for September 24, 2025; record date for voting is July 28, 2025.","Shareholder proposals for proxy inclusion must be received by July 28, 2025; director nominations also due July 28.","Universal proxy rule: shareholders soliciting proxies for director nominees must provide notice by July 28, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-065710","json":"https://secwatch.observer/filing/0001213900-25-065710.json","markdown":"https://secwatch.observer/filing/0001213900-25-065710.md","text":"https://secwatch.observer/filing/0001213900-25-065710.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025065710/0001213900-25-065710-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025065710/ea0249594-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:50:25.986242+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}